Humanized xenobiotic response in mice expressing nuclear receptor SXR

被引:557
作者
Xie, W
Barwick, JL
Downes, M
Blumberg, B
Simon, CM
Nelson, MC
Neuschwander-Tetri, BA
Bruntk, EM
Guzelian, PS
Evans, RM
机构
[1] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA
[2] Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA
[3] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA
[4] St Louis Univ, Sch Med, Dept Pathol, Kansas City, MO 64108 USA
[5] St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Kansas City, MO 64108 USA
关键词
D O I
10.1038/35019116
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The cytochrome CYP3A gene products, expressed in mammalian liver, are essential for the metabolism of lipophilic substrates, including endogenous steroid hormones and prescription drugs(1,2). CYP3A enzymes are extremely versatile and are inducible by many of their natural and xenobiotic substrates. Consequently, they form the molecular basis for many clinical drug-drug interactions(3). The induction of CYP3A enzymes is species-specific(4,5), and we have postulated that it involves one or more cellular factors, or receptor-like xeno-sensors(6). Here we identify one such factor unequivocally as the nuclear receptor pregnenolone X receptor (PXR)(7,8) and its human homologue, steroid and xenobiotic receptor (SXR)(8-10). We show that targeted disruption of the mouse PXR gene abolishes induction of CYP3A by prototypic inducers such as dexamethasone or pregnenolone-16 alpha-carbonitrile. In transgenic mice, an activated form of SXR causes constitutive upregulation of CYP3A gene expression and enhanced protection against toxic xenobiotic compounds. Furthermore, we show that the species origin of the receptor, rather than the promoter structure of CYP3A genes, dictates the species-specific pattern of CYP3A inducibility. Thus, we can generate 'humanized' transgenic mice that are responsive to human-specific inducers such as the antibiotic rifampicin. We conclude that SXR/PXR genes encode the primary species-specific xeno-sensors that mediate the adaptive hepatic response, and may represent the critical biochemical mechanism of human xenoprotection.
引用
收藏
页码:435 / 439
页数:6
相关论文
共 30 条
[1]  
Barwick JL, 1996, MOL PHARMACOL, V50, P10
[2]   Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction [J].
Bertilsson, G ;
Heidrich, J ;
Svensson, K ;
Åsman, M ;
Jendeberg, L ;
Sydow-Bäckman, M ;
Ohlsson, R ;
Postlind, H ;
Blomquist, P ;
Berkenstam, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12208-12213
[3]   SXR, a novel steroid and xenobiotic-sensing nuclear receptor [J].
Blumberg, B ;
Sabbagh, W ;
Juguilon, H ;
Bolado, J ;
van Meter, CM ;
Ono, ES ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3195-3205
[4]   Orphan nuclear receptors - new ligands and new possibilities [J].
Blumberg, B ;
Evans, RM .
GENES & DEVELOPMENT, 1998, 12 (20) :3149-3155
[5]  
BOCHERDING SM, 1992, ARCH INTERN MED, V152, P711
[6]   PARADOXICAL TRANSCRIPTIONAL ACTIVATION OF RAT-LIVER CYTOCHROME-P-450 3A1 BY DEXAMETHASONE AND THE ANTIGLUCOCORTICOID PREGNENOLONE 16-ALPHA-CARBONITRILE - ANALYSIS BY TRANSIENT TRANSFECTION INTO PRIMARY MONOLAYER-CULTURES OF ADULT-RAT HEPATOCYTES [J].
BURGER, HJ ;
SCHUETZ, JD ;
SCHUETZ, EG ;
GUZELIAN, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (06) :2145-2149
[7]   XENOBIOTIC-INDUCIBLE TRANSCRIPTION OF CYTOCHROME-P450 GENES [J].
DENISON, MS ;
WHITLOCK, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) :18175-18178
[8]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[9]  
GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P11
[10]   GENE STRUCTURE OF CYP3A4, AN ADULT-SPECIFIC FORM OF CYTOCHROME-P450 IN HUMAN LIVERS, AND ITS TRANSCRIPTIONAL CONTROL [J].
HASHIMOTO, H ;
TOIDE, K ;
KITAMURA, R ;
FUJITA, M ;
TAGAWA, S ;
ITOH, S ;
KAMATAKI, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (02) :585-595